Company Ceapro Inc Toronto S.E.
Equities
CZO
CA1499071076
Biotechnology & Medical Research
Business Summary
Managers
Managers | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 31/12/06 |
Director of Finance/CFO | - | 04/05/15 | |
Mitch Regnier
CTO | Chief Tech/Sci/R&D Officer | - | 30/04/23 |
Paul Moquin
CTO | Chief Tech/Sci/R&D Officer | - | 31/01/18 |
Chief Tech/Sci/R&D Officer | - | 31/12/09 | |
General Counsel | - | - | |
Leoni DeJoya
PRN | Corporate Officer/Principal | - | 06/01/19 |
52 | - |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Gilles Gagnon
CEO | Chief Executive Officer | 70 | 31/12/06 |
Ulrich Kosciessa
BRD | Director/Board Member | - | 26/04/15 |
William Li
BRD | Director/Board Member | 61 | 19/11/14 |
Ronald Miller
CHM | Chairman | - | 01/03/22 |
Geneviève Foster
BRD | Director/Board Member | - | 18/04/22 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 78,293,177 | 76,755,900 ( 98.04 %) | 0 | 98.04 % |
Company contact information
![address Ceapro Inc(CZO)](https://cdn.zonebourse.com/static/address/1409692.png)
Sector
1st Jan change | Capi. | |
---|---|---|
+22.15% | 46.55B | |
+45.94% | 41.84B | |
-2.37% | 40.84B | |
+33.84% | 32.95B | |
-6.35% | 28.27B | |
+20.42% | 27.78B | |
+48.83% | 14.26B | |
+45.00% | 13.69B | |
+0.06% | 12.18B |